Use of pulsed radio frequency
First Claim
1. A method for medical treatment of a disease or condition in a mammal, the method comprising using a pulse generator for applying a plurality of pulsed radiofrequency (PRF) stimulations over a period of between 2 min and 30 min, the stimulations comprising applying a signal with a frequency of 50,000 Hz-1,000,000 Hz and a voltage of 10 V-80 V delivered in pulse bursts with a duration of 0.1 msec-100 msec and burst frequency of 1/sec-20/sec by an electrode with an impedance of less than 1000 Ω
- intravascularly to the mammal to medically treat the disease or condition, wherein the disease or condition and corresponding treatment result is selected from the group consisting ofcancer and resulting in at least one of decreased mediastinal ingrowth, decrease in metastases, or decrease or absence of tumors;
diabetes and resulting in at least one of decreased blood sugar levels or decreased insulin requirement;
chronic obstructive pulmonary disease (COPD) and resulting in increased lung function;
rheumatoid arthritis and resulting in decreased in C-reactive protein (CRP) levels; and
osteoarthritis and resulting in decreased pain,wherein the medical treatment further results in activating the immune system or relieving pain and wherein PRF is applied together with vaccination.
1 Assignment
0 Petitions
Accused Products
Abstract
The invention relates to a method for medical treatment of a mammal, preferably a human, by applying pulsed radiofrequency (PRF) stimulation intravascularly. More particularly, said method has as effect that it boosts the immune system and/or that it relieves pain. In a preferred embodiment, the disease or condition to be treated is caused or accompanied by immunodeficiency, more preferably the disease or condition is selected from the group of cancer, infectious diseases, immunosuppression or otherwise caused immunodeficiencies. Also auto-immune diseases and conditions associated with allostatic load are preferred for treatment with the method of the invention. In an also preferred embodiment, the PRF stimulation is applied together with vaccination.
17 Citations
22 Claims
-
1. A method for medical treatment of a disease or condition in a mammal, the method comprising using a pulse generator for applying a plurality of pulsed radiofrequency (PRF) stimulations over a period of between 2 min and 30 min, the stimulations comprising applying a signal with a frequency of 50,000 Hz-1,000,000 Hz and a voltage of 10 V-80 V delivered in pulse bursts with a duration of 0.1 msec-100 msec and burst frequency of 1/sec-20/sec by an electrode with an impedance of less than 1000 Ω
- intravascularly to the mammal to medically treat the disease or condition, wherein the disease or condition and corresponding treatment result is selected from the group consisting of
cancer and resulting in at least one of decreased mediastinal ingrowth, decrease in metastases, or decrease or absence of tumors; diabetes and resulting in at least one of decreased blood sugar levels or decreased insulin requirement; chronic obstructive pulmonary disease (COPD) and resulting in increased lung function; rheumatoid arthritis and resulting in decreased in C-reactive protein (CRP) levels; and osteoarthritis and resulting in decreased pain, wherein the medical treatment further results in activating the immune system or relieving pain and wherein PRF is applied together with vaccination. - View Dependent Claims (2, 3, 4, 7, 8, 9, 10, 11, 12)
- intravascularly to the mammal to medically treat the disease or condition, wherein the disease or condition and corresponding treatment result is selected from the group consisting of
-
5. A method for medical treatment of a disease or condition in a mammal, the method comprising using a pulse generator for applying a plurality of pulsed radiofrequency (PRF) stimulations over a period of between 2 min and 30 min, the stimulations comprising applying a signal with a frequency of 50,000 Hz-1,000,000 Hz and a voltage of 10 V-80 V delivered in pulse bursts with a duration of 0.1 msec-100 msec and burst frequency of 1/sec-20/sec by an electrode with an impedance of less than 1000 Ω
- intravascularly to the mammal to medically treat the disease or condition, wherein the disease or condition and corresponding treatment result is selected from the group consisting of
cancer and resulting in at least one of decreased mediastinal ingrowth, decrease in metastases, or decrease or absence of tumors; diabetes and resulting in at least one of decreased blood sugar levels or decreased insulin requirement; chronic obstructive pulmonary disease (COPD) and resulting in increased lung function; rheumatoid arthritis and resulting in decreased in C-reactive protein (CRP) levels; and osteoarthritis and resulting in decreased pain, where PRF is given before, simultaneous with or after chemical, radiation or surgical treatment. - View Dependent Claims (14, 15, 16, 17, 18, 19, 20, 21, 22)
- intravascularly to the mammal to medically treat the disease or condition, wherein the disease or condition and corresponding treatment result is selected from the group consisting of
-
6. A method for treating immunodeficiency in a mammal, the method comprising using a pulse generator for administering intravascular pulse radiofrequency (PRF) stimulations over a period of between 2 min and 30 min, the stimulations comprising applying a signal with a frequency of 50,000 Hz-1,000,000 Hz and a voltage of 10 V-80 V delivered in pulse bursts with a duration of 0.1 msec-100 msec and burst frequency of 1/sec-20/sec by an electrode with an impedance of less than 1000 Ω
- to the mammal resulting in an increased immune response in the mammal wherein the medical treatment further results in activating the immune system or relieving pain and wherein PRF is applied together with vaccination.
-
13. A method for treating immunodeficiency in a mammal, the method comprising using a pulse generator for administering intravascular pulse radiofrequency (PRF) stimulations over a period of between 2 min and 30 min, the stimulations comprising applying a signal with a frequency of 50,000 Hz-1,000,000 Hz and a voltage of 10 V-80 V delivered in pulse bursts with a duration of 0.1 msec-100 msec and burst frequency of 1/sec-20/sec by an electrode with an impedance of less than 1000 Ω
- to the mammal resulting in an increased immune response in the mammal where PRF is given before, simultaneous with or after chemical, radiation or surgical treatment.
Specification